Last 12 months
Inside the activity.
1 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 1 | 11 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 14, 2026 20:06 UTC |
Myers Robert PaulChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002155916-26-000004 · form4-10142026_081046.xml · derivative · entry 2 Myers Robert Paul · CIK 0002155916 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of September 21, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of September 21, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| October 09, 2026 Filed Oct 14, 2026 20:06 UTC |
Myers Robert PaulChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $86.01 | $0.00 |
DisclosureSEC source: 0002155916-26-000004 · form4-10142026_081046.xml · derivative · entry 1 Myers Robert Paul · CIK 0002155916 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-10-08 F1 · derivative.exercise_date: 1/4th of the shares vest one year after September 21, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 00:38 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,892 | $0.00 Strike: $15.87 | $0.00 |
DisclosureSEC source: 0001614740-26-000014 · form4-10072026_121019.xml · derivative · entry 5 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,108 Underlying: Common Stock · 6,892 shares Expires 2032-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 00:38 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,305 | $0.00 Strike: $19.19 | $0.00 |
DisclosureSEC source: 0001614740-26-000014 · form4-10072026_121019.xml · derivative · entry 4 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,695 Underlying: Common Stock · 5,305 shares Expires 2031-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 00:38 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 6,892 | $15.87 | $109,376.04 |
DisclosureSEC source: 0001614740-26-000014 · form4-10072026_121019.xml · nonDerivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 00:38 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 5,305 | $19.19 | $101,802.95 |
DisclosureSEC source: 0001614740-26-000014 · form4-10072026_121019.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 20:10 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 9,943 | $98.37 | $978,092.91 |
DisclosureSEC source: 0001197350-26-000010 · form4-09152026_040901.xml · nonDerivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,745 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:10 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 18,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001197350-26-000010 · form4-09152026_040901.xml · derivative · entry 3 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:10 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 18,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001197350-26-000010 · form4-09152026_040901.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 22:54 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 658 | $100.00 | $65,800.00 |
DisclosureSEC source: 0001974200-26-000013 · form4-09032026_100913.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 616 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:52 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001614740-26-000013 · form4-09032026_100954.xml · derivative · entry 5 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,487 Underlying: Common Stock · 30,000 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:52 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 21,688 | $98.91 | $2,145,160.08 |
DisclosureSEC source: 0001614740-26-000013 · form4-09032026_100954.xml · nonDerivative · entry 3 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 194,440 F2 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F4 · price: The weighted average sale price for the transaction reported was $98.91, and the range of prices were between $98.49 and $99.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:52 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 8,312 | $98.08 | $815,240.96 |
DisclosureSEC source: 0001614740-26-000013 · form4-09032026_100954.xml · nonDerivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,128 F2 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F3 · price: The weighted average sale price for the transaction reported was $98.08, and the range of prices were between $97.47 and $98.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 22:52 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 30,000 | $2.94 | $88,080.00 |
DisclosureSEC source: 0001614740-26-000013 · form4-09032026_100954.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 131 shares of Common Stock that were acquired by the Reporting Person on May 10, 2026, pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 22:19 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001974200-26-000012 · form4-08192026_100826.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2029-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 22:19 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 40,000 | $100.00 | $4,000,000.00 |
DisclosureSEC source: 0001974200-26-000012 · form4-08192026_100826.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,274 Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 22:19 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionCommon Stock | 40,000 | $6.27 | $250,800.00 |
DisclosureSEC source: 0001974200-26-000012 · form4-08192026_100826.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2026 Filed Aug 12, 2026 21:14 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 6,001 | $99.90 | $599,509.50 |
DisclosureSEC source: 0001197350-26-000009 · form4-08122026_090835.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,355 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026. F2 · price: . The weighted average sale price for the transaction reported was $99.901633, and the range of prices were between $99.90 and $99.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. F3 · balance_after: Includes 175 shares of common stock that were acquired by the Reporting Person on May 10, 2026, pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 21:41 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001614740-26-000012 · form4-08112026_090838.xml · derivative · entry 6 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,487 Underlying: Common Stock · 20,000 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 21:41 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 2,300 | $100.14 | $230,322.00 |
DisclosureSEC source: 0001614740-26-000012 · form4-08112026_090838.xml · nonDerivative · entry 4 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 194,309 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F4 · price: The weighted average sale price for the transaction reported was $100.14, and the range of prices were between $99.995 and $100.2425. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 21:41 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 6,017 | $99.25 | $597,187.25 |
DisclosureSEC source: 0001614740-26-000012 · form4-08112026_090838.xml · nonDerivative · entry 3 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,609 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F3 · price: The weighted average sale price for the transaction reported was $99.25, and the range of prices were between $98.94 and $99.655. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 21:41 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 11,683 | $98.51 | $1,150,892.33 |
DisclosureSEC source: 0001614740-26-000012 · form4-08112026_090838.xml · nonDerivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202,626 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F2 · price: The weighted average sale price for the transaction reported was $98.51, and the range of prices were between $97.93 and $98.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 21:41 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 20,000 | $2.94 | $58,720.00 |
DisclosureSEC source: 0001614740-26-000012 · form4-08112026_090838.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:26 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 1,840 | $105.29 | $193,733.60 |
DisclosureSEC source: 0001974200-26-000011 · form4-08052026_080847.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,274 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:12 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001614740-26-000011 · form4-07082026_090744.xml · derivative · entry 7 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,487 Underlying: Common Stock · 20,000 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:12 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,710 | $124.79 | $213,390.90 |
DisclosureSEC source: 0001614740-26-000011 · form4-07082026_090744.xml · nonDerivative · entry 5 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 194,309 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F5 · price: The weighted average sale price for the transaction reported was $124.79, and the range of prices were between $124.27 and $124.94. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:12 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 1,975 | $123.74 | $244,386.50 |
DisclosureSEC source: 0001614740-26-000011 · form4-07082026_090744.xml · nonDerivative · entry 4 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,019 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F4 · price: The weighted average sale price for the transaction reported was $123.74, and the range of prices were between $123.24 and $124.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:12 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 4,181 | $122.34 | $511,503.54 |
DisclosureSEC source: 0001614740-26-000011 · form4-07082026_090744.xml · nonDerivative · entry 3 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,994 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F3 · price: The weighted average sale price for the transaction reported was $122.34, and the range of prices were between $122.13 and $123.1125. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:12 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 12,134 | $121.65 | $1,476,101.10 |
DisclosureSEC source: 0001614740-26-000011 · form4-07082026_090744.xml · nonDerivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 202,175 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2026. F2 · price: The weighted average sale price for the transaction reported was $121.65, and the range of prices were between $121.11 and $122.105. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:12 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 20,000 | $2.94 | $58,720.00 |
DisclosureSEC source: 0001614740-26-000011 · form4-07082026_090744.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:07 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 300 | $124.94 | $37,482.00 |
DisclosureSEC source: 0001197350-26-000008 · form4-07082026_090727.xml · nonDerivative · entry 4 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,181 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:07 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 528 | $123.84 | $65,387.52 |
DisclosureSEC source: 0001197350-26-000008 · form4-07082026_090727.xml · nonDerivative · entry 3 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,481 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026. F4 · price: . The weighted average sale price for the transaction reported was $123.84, and the range of prices were between $123.285 and $124.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:07 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,048 | $122.43 | $128,306.64 |
DisclosureSEC source: 0001197350-26-000008 · form4-07082026_090727.xml · nonDerivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,009 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026. F3 · price: . The weighted average sale price for the transaction reported was $122.43, and the range of prices were between $122.235 and $123.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 21:07 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 3,124 | $121.67 | $380,097.08 |
DisclosureSEC source: 0001197350-26-000008 · form4-07082026_090727.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,057 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 9, 2026. F2 · price: . The weighted average sale price for the transaction reported was $121.67, and the range of prices were between $121.13 and $122.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:01 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 2,721 | $120.00 | $326,520.00 |
DisclosureSEC source: 0001974200-26-000010 · form4-07022026_100751.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,114 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. Read SEC document |
| June 17, 2026 Filed Jun 18, 2026 22:39 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 2,594 | $101.95 | $264,458.30 |
DisclosureSEC source: 0001974200-26-000009 · form4-06182026_100638.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,835 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Cardon LonDirector
|
GrantRestricted Stock Units · Derivative | 1,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001854337-26-000004 · form4-06172026_080618.xml · derivative · entry 2 Cardon Lon · CIK 0001854337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Cardon LonDirector
|
GrantStock Option (right to buy) · Derivative | 3,772 | $0.00 Strike: $101.00 | $0.00 |
DisclosureSEC source: 0001854337-26-000004 · form4-06172026_080618.xml · derivative · entry 1 Cardon Lon · CIK 0001854337 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 Underlying: Common Stock · 3,772 shares Expires 2036-06-14 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Walbert Timothy PDirector
|
GrantRestricted Stock Units · Derivative | 1,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001349376-26-000004 · form4-06172026_080620.xml · derivative · entry 2 Walbert Timothy P · CIK 0001349376 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Walbert Timothy PDirector
|
GrantStock Option (right to buy) · Derivative | 3,772 | $0.00 Strike: $101.00 | $0.00 |
DisclosureSEC source: 0001349376-26-000004 · form4-06172026_080620.xml · derivative · entry 1 Walbert Timothy P · CIK 0001349376 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 Underlying: Common Stock · 3,772 shares Expires 2036-06-14 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Fairey WilliamDirector
|
GrantDeferred Stock Units · Derivative | 1,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001727275-26-000004 · form4-06172026_080609.xml · derivative · entry 2 Fairey William · CIK 0001727275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Fairey WilliamDirector
|
GrantStock Option (right to buy) · Derivative | 3,772 | $0.00 Strike: $101.00 | $0.00 |
DisclosureSEC source: 0001727275-26-000004 · form4-06172026_080609.xml · derivative · entry 1 Fairey William · CIK 0001727275 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 Underlying: Common Stock · 3,772 shares Expires 2036-06-14 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Ramasastry SairaDirector
|
GrantRestricted Stock Units · Derivative | 1,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001547959-26-000016 · form4-06172026_080616.xml · derivative · entry 2 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Ramasastry SairaDirector
|
GrantStock Option (right to buy) · Derivative | 3,772 | $0.00 Strike: $101.00 | $0.00 |
DisclosureSEC source: 0001547959-26-000016 · form4-06172026_080616.xml · derivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 Underlying: Common Stock · 3,772 shares Expires 2036-06-14 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Brege LauraDirector
|
GrantDeferred Stock Units · Derivative | 1,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001365619-26-000005 · form4-06172026_080608.xml · derivative · entry 2 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Brege LauraDirector
|
GrantStock Option (right to buy) · Derivative | 3,772 | $0.00 Strike: $101.00 | $0.00 |
DisclosureSEC source: 0001365619-26-000005 · form4-06172026_080608.xml · derivative · entry 1 Brege Laura · CIK 0001365619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 Underlying: Common Stock · 3,772 shares Expires 2036-06-14 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Heron Patrick JDirector
|
GrantDeferred Stock Units · Derivative | 1,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001365617-26-000004 · form4-06172026_080605.xml · derivative · entry 2 Heron Patrick J · CIK 0001365617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Heron Patrick JDirector
|
GrantStock Option (right to buy) · Derivative | 3,772 | $0.00 Strike: $101.00 | $0.00 |
DisclosureSEC source: 0001365617-26-000004 · form4-06172026_080605.xml · derivative · entry 1 Heron Patrick J · CIK 0001365617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 Underlying: Common Stock · 3,772 shares Expires 2036-06-14 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Fischer LaurentDirector
|
GrantDeferred Stock Units · Derivative | 1,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001379344-26-000005 · form4-06172026_080603.xml · derivative · entry 2 Fischer Laurent · CIK 0001379344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. F2 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. F2 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of the Issuer's common stock and will vest on the first anniversary of the grant date, provided that it will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Each vested deferred stock unit will be paid out in the Issuer's common stock upon the earliest to occur of (i) a change in control of the Issuer and (ii) within 60 days following separation from service with the Issuer. Read SEC document |
| June 15, 2026 Filed Jun 18, 2026 00:30 UTC |
Fischer LaurentDirector
|
GrantStock Option (right to buy) · Derivative | 3,772 | $0.00 Strike: $101.00 | $0.00 |
DisclosureSEC source: 0001379344-26-000005 · form4-06172026_080603.xml · derivative · entry 1 Fischer Laurent · CIK 0001379344 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,772 Underlying: Common Stock · 3,772 shares Expires 2036-06-14 F1 · derivative.exercise_date: The shares vest on the first anniversary of the grant date, provided that the option will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.